• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

H1N1 (2009) Influenza A infection in transplant recipient patients: A comparative study versus non-transplanted patients

tetano

Editor, Senior Moderator
Rev Pneumol Clin. 2011 Sep;67(4):199-208. Epub 2011 Aug 5.
[H1N1 (2009) Influenza A infection in transplant recipient patients: A comparative study versus non-transplanted patients].
[Article in French]
Crockett F, Mal H, Amazzough K, Stern M, Rivaud E, Cerf C, Matthieu E, Honderlick P, Scherrer A, Couderc LJ.
Source

Service de pneumologie, h?pital Foch, 40, rue Worth, 92150 Suresnes, France.
Abstract
OBJECTIVE:

To compare H1N1 (2009) influenza A infection characteristics between transplant recipient patients and non-transplanted patients. To assess the evolution of transplanted patients up to 6months following infection.
METHODS:

Patients diagnosed with confirmed influenza A infection from three Parisian transplant centers between September 1st, 2009 and February 15th, 2010. Clinical symptoms, biological, and radiological findings, and management were analysed and retrospectively compared between transplanted (T) and non-transplanted patients (NT). The evolution was assessed by a follow-up questionnaire, CT results 1 to 3months after influenza infection and FEV1 variation.
RESULTS:

Seventy patients were included. Thirteen patients had an allograft (lung: eight, kidney: four, stem cells: one): (1) hospitalization: 100% (13 out of 13) in group T, 54% (31 out of 57) in group NT (P=0.0013); (2) pneumonia: 62% (eight out of 13) in group T, 26% (eight out of 57) in group NT (P=0.004); (3) mortality rate among hospitalized patients: 7.7% (one out of 13) in the group T, 9.7% (three out of 57) in group NT (P=NS); (4) chest CT scan abnormalities remained in four lung transplanted patients; (5) a minimum 10% decrease in FEV1 was detected in four lung transplant recipients.
CONCLUSION:

Our results suggest that H1N1(2009) influenza A infection in transplant recipient patients compared to non-transplanted patients: (1) more often leads to hospitalization; (2) is more frequently associated with pneumonia; (3) is responsible for a persistent graft functional impairment in lung transplant recipients; (4) has a low mortality rate similar to admitted non-transplanted patients.

Copyright ? 2011 Elsevier Masson SAS. All rights reserved.

PMID:
21920278
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/21920278
 
Back
Top Bottom